Skip to main content
. 2021 Jul 28;12:699217. doi: 10.3389/fimmu.2021.699217

Table 3.

HBV seromarker distribution of non-resolved donations, the remaining non-resolved and resolved negative donations.

Seromarkers Non-resolved donations (%) Remaining non-resolved donations (%) Resolved negative donations (%) P
N=252 (42 pools) N=150 (25 pools) N=85*
Anti-HBc+ 134 (53.2) 79 (52.6) 38 (44.7) 0.15
Anti-HBc+/anti-HBs+ 116 (46) 68 (45.3) 37 (43.5) 0.699
Anti-HBc+/ anti-HBs− 18 (7.1) 11 (7.3) 1 (1.2) 0.131
Anti-HBc− 118 (46.8) 71 (47.4) 47 (55.3) 0.723
Anti-HBc−/ anti-HBs+ 71 (28.2) 43 (28.7) 29 (34.1) 0.740
Anti-HBc−/ anti-HBs− 47 (18.6) 28 (18.7) 18 (21.2) 0.90
Total(%) 252 (100) 150 (100.0) 85 (100.0)

*Donations were identified negative from 17 resolved pools. The rates of anti-HBc alone in non-resolved donations (42 pools) and in the remaining non-resolved donations (25 pools) were significantly higher than that in resolved negative donations (P = 0.032 and P = 0.033, one-sided fisher’s exact).